Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 1, 2026

Treatment of Middle-segment Pancreatic Benign Tumor Using Laparoscopic Central Pancreatectomy with End-to-end Pancreatic Duct Reconstruction
05:11

Treatment of Middle-segment Pancreatic Benign Tumor Using Laparoscopic Central Pancreatectomy with End-to-end Pancreatic Duct Reconstruction

Published on: January 2, 2026

Middle segmental pancreatic resection--a single-centre experience.

Róbert Papp1, László Cseke, Ors Péter Horváth

  • 1Department of Surgery, Medical Faculty of Pécs University, Pécs, Hungary.

Hepato-Gastroenterology
|June 14, 2011
PubMed
Summary

Middle segmental pancreatic resection is a viable surgical option for pancreatic lesions and trauma, demonstrating acceptable morbidity and preserved organ function. Careful patient selection and precise surgical technique are crucial for optimal outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Discovery of RP-2119: A Potent, Selective, and Orally Bioavailable Polθ ATPase Inhibitor.

Journal of medicinal chemistry·2025
Same author

Discovery of RP-1664: A First-in-Class Orally Bioavailable, Selective PLK4 Inhibitor.

Journal of medicinal chemistry·2025
Same author

[Our innovations for the reduction of postoperative pancreatic fistula output].

Magyar sebeszet·2024
Same author

PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer.

Molecular cancer therapeutics·2024
Same author

Identification and Biosynthesis of an N-Glucuronide Metabolite of Camonsertib.

Drug metabolism and disposition: the biological fate of chemicals·2024
Same author

[One of the most influential Hungarian surgeons in the second half of the 20th century, József Imre (1930-1980)].

Orvosi hetilap·2024

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Pancreatic Surgery

Background:

  • Middle segmental pancreatic resection (MSPR) is a specialized surgical procedure.
  • Experience with MSPR for benign, low-grade malignant pancreatic lesions, and trauma is limited.

Purpose of the Study:

  • To report a single-center experience with MSPR.
  • To review the technique and indications for MSPR.

Main Methods:

  • Seven MSPRs were performed over seven years for various pancreatic conditions.
  • The surgical technique involved Roux-en-Y anastomosis, proximal stump closure, and omental coverage in later cases.

Main Results:

  • The study included 8 patients, with 3 complications (37.5%) and a 12% surgical morbidity rate.

More Related Videos

Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors
02:20

Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors

Published on: February 9, 2024

Related Experiment Videos

Last Updated: Jun 1, 2026

Treatment of Middle-segment Pancreatic Benign Tumor Using Laparoscopic Central Pancreatectomy with End-to-end Pancreatic Duct Reconstruction
05:11

Treatment of Middle-segment Pancreatic Benign Tumor Using Laparoscopic Central Pancreatectomy with End-to-end Pancreatic Duct Reconstruction

Published on: January 2, 2026

Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors
02:20

Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors

Published on: February 9, 2024

  • No reoperations or deaths occurred.
  • Postoperative endocrine and exocrine pancreatic functions remained normal in all patients during follow-up.

    • Conclusions:

    • MSPR can be performed with an acceptable morbidity rate.
    • Appropriate patient selection and meticulous surgical technique are essential for successful MSPR outcomes.